1. Kinney MV, Kerber KJ, Black RE, Cohen B, Nkrumah F, Coovadia H, et al. Sub-Saharan Africa’s Mothers, Newborns, and Children: Where and Why Do They Die? PLoS Med. 2010;7(6). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888581/ Accessed 10 May 2021
2. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99(7):547‑53.
3. Moodley J. Maternal deaths due to hypertensive disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2008;22(3):559‑67
4. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56‑9.
5. Firoz T, Sanghvi H, Merialdi M, von Dadelszen P. Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):537‑48.
6. Goldenberg RL, Jones B, Griffin JB, Rouse DJ, Kamath-Rayne BD, Trivedi N, et al. Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work? Acta Obstet Gynecol Scand. 2015;94(2):148‑55. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.12533 Accessed 10 May 2021
7. Goldenberg RL, McClure EM, Macguire ER, Kamath BD, Jobe AH. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2011;113(2):91‑5.
8. Committee Opinion No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia. Obstet Gynecol. 2015 ;126(3): e25. https://journals.lww.com/greenjournal/Fulltext/2015/09000/Committee_Opinion_No 638 First_Trimester_Risk.49.aspx Accessed 10 May 2021
9. Redman CWG. Hypertension in pregnancy: the NICE guidelines. Heart Br Card Soc. 2011;97(23):1967‑9. https://www.ncbi.nlm.nih.gov/pubmed/21990386 Accessed 10 May 2021
10. Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ. 2010 ;341 :c2207. https://www.ncbi.nlm.nih.gov/pubmed/20739360 Accessed 10 May 2021
11. World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva: World Health Organization; 2016. (WHO Guidelines Approved by the Guidelines Review Committee). http://www.ncbi.nlm.nih.gov/books/NBK409108/ Accessed 10 May 2021
12. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2014;36(5):416‑41. https://www.ncbi.nlm.nih.gov/pubmed/24927294 Accessed 10 May 2021
13. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018; 13:291‑310.
14. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613‑22. https://www.nejm.org/doi/full/10.1056/NEJMoa1704559 Accessed 10 May 2021
15. Greene MF, Solomon CG. Aspirin to Prevent Preeclampsia. N Engl J Med. 2017;377(7):690‑1. https://www.nejm.org/doi/full/10.1056/NEJMe1708920 Accessed 10 May 2021
16. Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study. J Perinatol. 2015;35(5):328‑31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838902/ Accessed 10 May 2021
17. Rolnik D. L., O’Gorman N., Roberge S., Bujold E., Hyett J., Uzan S., et al. Early screening and prevention of preterm pre‐eclampsia with aspirin: time for clinical implementation. Ultrasound Obstet Gynecol. 2017;50(5):551‑6. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/uog.18899 Accessed 10 May 2021
18. Okusanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, Qureshi Z, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG Int J Obstet Gynaecol. 2016;123(3):356‑66. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737322/ Accessed 10 May 2021
19. Khooshideh M, Ghaffarpour M, Bitarafan S. The comparison of anti-seizure and tocolytic effects of phenytoin and magnesium sulphate in the treatment of eclampsia and preeclampsia: A randomised clinical trial. Iran J Neurol. 2017 ;16(3):125‑9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673984/ Accessed 10 May 2021
20. Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynecol. 2017;216(2):141.e1-141.e5. https://www.ncbi.nlm.nih.gov/pubmed/27659212 Accessed 10 May 2021
21. Rawlins B, Plotkin M, Rakotovao JP, Getachew A, Vaz M, Ricca J, et al. Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries. BMC Pregnancy Childbirth. 2018;18(1):346. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108136/ Accessed 10 May 2021
22. WHO. Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019. http://www.who.int/reproductivehealth/publications/maternal-mortality-2000-2017/en/ Accessed 10 May 2021
23. The DHS Program - Quality information to plan, monitor and improve population, health, and nutrition programs. https://www.dhsprogram.com/ Accessed 10 May 2021
24. Tandu-Umba B, Mbangama MA, Kamongola KMB, Kamgang Tchawou AG, Kivuidi MP, Kasonga Munene S, et al. Pre-pregnancy high-risk factors at first antenatal visit: how predictive are these of pregnancy outcomes? Int J Womens Health. 2014 ;6 :1011‑8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266255/ Accessed 10 May 2021
25. Nkamba DM, Ditekemena J, Wembodinga G, Bernard P, Tshefu A, Robert A. Proportion of pregnant women screened for hypertensive disorders in pregnancy and its associated factors within antenatal clinics of Kinshasa, Democratic Republic of Congo. BMC Pregnancy Childbirth. 2019 ;19(1):297. https://doi.org/10.1186/s12884-019-2435-z Accessed 10 May 2021
26. École de Santé Publique, Université de Kinshasa, ICF. Évaluation de la Prestation des Services de Soins de Santé 2017-2018 : Rapport de synthèse. Rockville, Maryland, USA : ESPK et ICF; 2019.
27. Tanaka M, Tsujimoto Y, Goto K, Kumahara K, Onishi S, Iwanari S, et al. Preeclampsia before 20 weeks of gestation: a case report and review of the literature. CEN Case Rep 2014;4(1):55‑60. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411624/ Accessed 10 May 2021
28. Bazant E, Rakotovao JP, Rasolofomanana JR, Tripathi V, Gomez P, Favero R, et al. Quality of care to prevent and treat postpartum hemorrhage and pre-eclampsia/eclampsia : an observational assessment in Madagascar’s hospitals. Med Sante Trop. 2013;23(2):168‑75.
29. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. 4th edition. Australia; Belmont, CA:Duxbury Press; 2007.
30. République Démocratique du Congo, Ministère de la Santé Publique. Normes et directives des interventions intégrées de santé de la mère, du nouveau-né et de l’enfant en République Démocratique du Congo. Volume 1 soins : obstétricaux essentiels. Kinshasa; 2012.
31. Akaishi R, Yamada T, Morikawa M, Nishida R, Minakami H. Clinical features of isolated gestational proteinuria progressing to pre-eclampsia: retrospective observational study. BMJ Open. 2014;4(4): e004870.
32. Shinar S, Asher-Landsberg J, Schwartz A, Ram-Weiner M, Kupferminc MJ, Many A. Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria. J Perinatol Off J Calif Perinat Assoc. 2016 ;36(1):25‑9.
33. République Démocratique du Congo, Ministère de la Santé Publique. Rapport final cartographie de la SMNE. Kinshasa 2012. http://familyplanning-drc.net/docs/Rapport%20final%20cartographie%20de%20la%20SMNE%2029%20octobre%202012.pdf Accessed 10 May 2021
34. Mpunga Mukendi D, Chenge F, Mapatano MA, Criel B, Wembodinga G. Distribution and quality of emergency obstetric care service delivery in the Democratic Republic of the Congo: it is time to improve regulatory mechanisms. Reprod Health. 2019;16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631736/ Accessed 10 May 2021
35. Arsenault C, Jordan K, Lee D, Dinsa G, Manzi F, Marchant T, et al. Equity in antenatal care quality: an analysis of 91 national household surveys. Lancet Glob Health. 2018;6(11):e1186‑95.
36. Institut national de la statistique. Enquête par grappes à indicateurs multiples, 2017-2018, rapport de résultats de l’enquête. Kinshasa, République Démocratique du Congo. Kinshasa. 2019.
37. Ministère du Plan et Suivi de la Mise en oeuvre de la Révolution de la Modernité (MPSMRM), Ministère de la Santé Publique, ICF International. Enquête Démographique et de Santé en République Démocratique du Congo 2013-2014. Rockville, Maryland. USA : MPSMRM, MSP et ICF International; 2014. https://dhsprogram.com/pubs/pdf/FR300/FR300.pdf Accessed 10 May 2021
38. Ngo T-T-D, Nguyen T-D, Goyens P, Robert A. Misuse of antenatal care and its association with adverse outcomes of pregnancy in a Southern rural area of Vietnam. Health Care Women Int. 2018;39(4):472‑92. https://www.ncbi.nlm.nih.gov/pubmed/29111908 Accessed 10 May 2021
39. Babalola S. Women’s Education Level, Antenatal Visits and the Quality of Skilled Antenatal Care: A Study of Three African Countries. J Health Care Poor Underser. 2014 ;25(1):161‑79. http://search.proquest.com/docview/1503121491/abstract/374964B02E9F4EBCPQ/1 Accessed 10 May 2021
40. Barber SL, Bertozzi SM, Gertler PJ. Variations in prenatal care quality for the rural poor in Mexico. Health Aff Proj Hope. 2007;26(3):w310-323.
41. Geleto A, Chojenta C, Musa A, Loxton D. WOMEN’s Knowledge of Obstetric Danger signs in Ethiopia (WOMEN’s KODE):a systematic review and meta-analysis. Syst Rev. 2019;8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388496/ Accessed 10 May 2021
42. Akeju DO, Vidler M, Sotunsa JO, Osiberu MO, Orenuga EO, Oladapo OT, et al. Human resource constraints and the prospect of task-sharing among community health workers for the detection of early signs of pre-eclampsia in Ogun State, Nigeria. Reprod Health. 2016;13(2):111. https://doi.org/10.1186/s12978-016-0216-y Accessed 10 May 2021
43. Warren C, Salisu Ishaku, Ayodeji B O, Adoyi G, Karen R. K, Amy Dempsey. Landscaping analysis for pre-eclampsia and eclampsia in Nigeria. Abuja: Federal Capital Territory: Population Council; 2015 p. 36. http://www.endingeclampsia.org/wp-content/uploads/2017/04/EndingEclampsia-LandscapeReport-Nigeria.pdf Accessed 10 May 2021